Emily A Voigt
Emily A Voigt
1RNA Vaccines, Access to Advanced Health Institute (AAHI), Seattle, WA 98102 USA
1,✉,
Alana Gerhardt
Alana Gerhardt
2Product Development, Access to Advanced Health Institute (AAHI), Seattle, WA 98102 USA
2,
Derek Hanson
Derek Hanson
1RNA Vaccines, Access to Advanced Health Institute (AAHI), Seattle, WA 98102 USA
1,
Madeleine F Jennewein
Madeleine F Jennewein
1RNA Vaccines, Access to Advanced Health Institute (AAHI), Seattle, WA 98102 USA
1,
Peter Battisti
Peter Battisti
1RNA Vaccines, Access to Advanced Health Institute (AAHI), Seattle, WA 98102 USA
1,
Sierra Reed
Sierra Reed
2Product Development, Access to Advanced Health Institute (AAHI), Seattle, WA 98102 USA
2,
Jasneet Singh
Jasneet Singh
1RNA Vaccines, Access to Advanced Health Institute (AAHI), Seattle, WA 98102 USA
1,
Raodoh Mohamath
Raodoh Mohamath
3Formulation Sciences, Access to Advanced Health Institute (AAHI), Seattle, WA 98102 USA
3,
Julie Bakken
Julie Bakken
1RNA Vaccines, Access to Advanced Health Institute (AAHI), Seattle, WA 98102 USA
1,
Samuel Beaver
Samuel Beaver
1RNA Vaccines, Access to Advanced Health Institute (AAHI), Seattle, WA 98102 USA
1,
Christopher Press
Christopher Press
2Product Development, Access to Advanced Health Institute (AAHI), Seattle, WA 98102 USA
2,
Patrick Soon-Shiong
Patrick Soon-Shiong
4ImmunityBio, Inc, Culver City, CA 90232 USA
4,
Christopher J Paddon
Christopher J Paddon
5Amyris, Inc, Emeryville, CA 94608 USA
5,
Christopher B Fox
Christopher B Fox
3Formulation Sciences, Access to Advanced Health Institute (AAHI), Seattle, WA 98102 USA
6Department of Global Health, University of Washington, Seattle, WA 98195 USA
3,6,
Corey Casper
Corey Casper
1RNA Vaccines, Access to Advanced Health Institute (AAHI), Seattle, WA 98102 USA
2Product Development, Access to Advanced Health Institute (AAHI), Seattle, WA 98102 USA
3Formulation Sciences, Access to Advanced Health Institute (AAHI), Seattle, WA 98102 USA
6Department of Global Health, University of Washington, Seattle, WA 98195 USA
7Department of Medicine, University of Washington, Seattle, WA 98195 USA
8Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109 USA
1,2,3,6,7,8
1RNA Vaccines, Access to Advanced Health Institute (AAHI), Seattle, WA 98102 USA
2Product Development, Access to Advanced Health Institute (AAHI), Seattle, WA 98102 USA
3Formulation Sciences, Access to Advanced Health Institute (AAHI), Seattle, WA 98102 USA
4ImmunityBio, Inc, Culver City, CA 90232 USA
5Amyris, Inc, Emeryville, CA 94608 USA
6Department of Global Health, University of Washington, Seattle, WA 98195 USA
7Department of Medicine, University of Washington, Seattle, WA 98195 USA
8Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109 USA
Subject terms: RNA vaccines, RNA vaccines
© The Author(s) 2022
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.